A PREFERRED 1L REGIMEN OPTION (CATEGORY 1 RECOMMENDATION)10
- aCategory 1: Based upon high-level evidence, there is uniform NCCN consensus that the intervention is appropriate.10
- bGood performance status for this regimen (AG) is defined as KPS ≥70, so some patients with an ECOG score of 2 may be eligible to receive this regimen (AG).10
- cAccording to the NCCN Chemotherapy Order Templates: Peer-reviewed statements of consensus of its authors derived from the NCCN Guidelines®.
- The albumin-bound paclitaxel (ABRAXANE) Phase III MPACT study enrolled patients with KPS ≥70.10 Good performance status is defined as ECOG 0-1, with good biliary drainage and adequate nutritional intake, and ECOG 0-2 if considering gemcitabine + albumin-bound paclitaxel.10 Please refer to the NCCN Guidelines for pancreatic cancer for a complete list of recommended treatment options. AG=ABRAXANE + gemcitabine.